Agilent Cytation 9 Cell Imaging Multimode Reader, or equivalent instrument

The FDA Office of Acquisition and Grant Services is issuing a Sources Sought Notice to identify small business sources capable of supplying an Agilent Cytation 9 Cell Imaging Multimode Reader or equivalent instrument, with responses due by June 22, 2026 at 12:00 pm Central Time. This is a market survey for written information only; no contract will be awarded from this announcement.

The FDA seeks sources under NAICS 334516 (Analytical Laboratory Instrument Manufacturing) with a 1,000-employee small business threshold, though all interested parties may respond. The instrument must perform automated high-throughput image acquisition in multi-well plate formats with configurable upright and inverted microscopy, multimode detection (fluorescence, absorbance, luminescence), and integration with automated incubators. Technical specifications require a 16-bit CMOS camera with dynamic range exceeding 65,000 fluorescence units, operation on standard 120V 15-amp power, and bundled image analysis software.

Delivery, installation, and on-site training for 3–5 users must be completed within 60 days of contract award at the FDA/NCTR facility in Jefferson, Arkansas. The contractor must be an authorized Agilent reseller with written OEM verification, provide one year of warranty and unlimited technical support, and possess an active instrument buyback program with Agilent Technologies. A minimum 43.1% manufacturer-backed credit must apply toward the equipment quote for the legacy Cytation 3 System (Serial No. 160920B) offered as trade-in.

Responses should include business information, three-year past performance data, technical specifications, GSA Schedule details if applicable, and informational pricing. Submit to suzanne.martella@fda.hhs.gov, referenced as 75F40126SSN135511.